Beijing Tong Ren Tang Chinese Medicine Co (HK:3613) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Beijing Tong Ren Tang Chinese Medicine Company Limited has released its unaudited interim results for the first half of 2024, which are now available for shareholders and interested parties. The report, in compliance with the Hong Kong Stock Exchange listing rules, will be accessible both in print and on the company’s website by September 30, 2024. These results reflect the latest financial performance of the company and its subsidiaries.
For further insights into HK:3613 stock, check out TipRanks’ Stock Analysis page.